DrugEx v2: de novo design of drug molecules by Pareto-based multi-objective reinforcement learning in polypharmacology
Abstract In polypharmacology drugs are required to bind to multiple specific targets, for example to enhance efficacy or to reduce resistance formation. Although deep learning has achieved a breakthrough in de novo design in drug discovery, most of its applications only focus on a single drug target...
Guardado en:
Autores principales: | Xuhan Liu, Kai Ye, Herman W. T. van Vlijmen, Michael T. M. Emmerich, Adriaan P. IJzerman, Gerard J. P. van Westen |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMC
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0871ce20cd084c358f772f94aba024a5 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
MOTION LEARNING USING SPATIO-TEMPORAL NEURAL NETWORK
por: Nooraini Yusoff, et al.
Publicado: (2020) -
DockStream: a docking wrapper to enhance de novo molecular design
por: Jeff Guo, et al.
Publicado: (2021) -
Machine Learning-Based Prediction of Drug-Drug Interactions for Histamine Antagonist Using Hybrid Chemical Features
por: Luong Huu Dang, et al.
Publicado: (2021) -
Perancangan Sistem Informasi E-Learning pada SMAN ABC
por: TB E Zaki Baihaki, et al.
Publicado: (2021) -
A machine learning based framework for assisting pathologists in grading and counting of breast cancer cells
por: Sreeraj M., et al.
Publicado: (2021)